CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
is evaluating a drug called Avelumab alone and in combination with Talazoparib or Axitinib as a possible treatment for recurrent or metastatic endometrial...
Phase 2
Boston, Massachusetts, United States and 3 other locations
This research study is studying a drug combination as a possible treatment for endometrial cancer.The drugs involved in this study ...
Phase 2
Boston, Massachusetts, United States and 2 other locations
The purpose of this research study is to see if the combination of study drugs avelumab and M1774 is effective and safe for participants with endometrial...
Phase 2
Boston, Massachusetts, United States and 1 other location
A Phase 2 Multi-center Open-label Trial of nab-Sirolimus in Combination with Letrozole in Advanced or Recurrent Endometrioid Endometrial Cancer...
Phase 2
Providence, Rhode Island, United States and 8 other locations
This research study is studying a combination of targeted therapies as a possible treatment for estrogen-receptor positive (ER+) endometrial ...
Phase 2
Boston, Massachusetts, United States and 2 other locations
This is a Phase IB/II multi-cohort study designed to evaluate the efficacy and safety of targeted agents with or without cancer immune check ...
Phase 1, Phase 2
Boston, Massachusetts, United States and 20 other locations
A standard treatment for endometrial cancer is chemotherapy and pembrolizumab together followed by pembrolizumab maintenance for tw...
Phase 2
Boston, Massachusetts, United States and 5 other locations
letrozole in advanced stage, persistent or recurrent endometrioid endometrial cancer at 6 months. Treatment will continue until eit...
Phase 2
Boston, Massachusetts, United States and 28 other locations
Researchers are looking for new ways to treat people with endometrial cancer (EC) who have previously received treatment with plati...
Phase 3
Worcester, Massachusetts, United States and 218 other locations
for maintenance selinexor in participants with advanced or recurrent endometrial cancer. Participants with primary stage IV or recu...
Phase 3
Providence, Rhode Island, United States and 77 other locations
Clinical trials
Research sites
Resources
Legal